Under a joint initiative by the Fonds de recherche du Québec and Génome Québec, a task force combining research teams from across the province, including those of the University of Montreal Hospital Research Centre (CRCHUM) and the Université de Montréal, will set up the first Quebec Biobank to advance research efforts studying COVID-19, a disease caused by a new type of virus in the coronaviru
A New Multidisciplinary Approach for Detecting and Treating Amyloidosis
What do heart failure, bruising around the eyes and carpal tunnel syndrome have in common? They are a few of the many signs and symptoms seen in patients with amyloidosis, a rare but often fatal disease for which the CHUM now offers a new treatment approach.
Montreal, November 22, 2019 ─ A hospital corridor has been transformed into an exercise track for patients in the CHUM’s stroke unit, thanks to the new LOCOMOTIVE circuit that provides information and exercises to get patients moving, keep their minds active and encourag
Montréal, November 14, 2018 — Today, CHUM and Université de Montréal announce the creation of the first school of artificial intelligence applied to the health sector from a Francophone environment, the École de l'intelligence artificielle en santé du CHUM (EIAS).
On 20 October 2018, Dr. Pierrette Gaudreau , a researcher at, CHUM Research Center (CRCHUM) was awarded the Contribution to Gerontology Award by the Canadian Association on Gerontology (CAG).
Naglaa Shoukry, Ph. D., and her team have made a significant breakthrough in their research aiming to limit the progression of liver disease.
The multi-institutional Montreal Cancer Consortium (MCC) comprises the Université de Montréal Hospital Centre Rese
CHUM (Centre hospitalier de l’Université de Montréal) and CRCHUM (its research centre) are now working on a pioneering cancer immunotherapy that employs immune cell infusion. This ground-breaking, personalized approach treats patients using cells taken from their own tumours.